knowledge -WSS

knowledge

author：entertainment 2025-09-03 14:35:26 - browse：2735

The term “excited delirium” has been used for years by law enforcement and other first responders, including health care workers, to describe people who exhibit behavior that is considered “out of control.” This diagnosis has been applied again and again, even posthumously, as a justification for extreme, and sometimes deadly, interventions by law enforcement. It came up most recently in the trials of two police officers accused of causing the death of Elijah McClain, a Colorado man; both officers were acquitted this week.

But excited delirium is not an evidence-based medical diagnosis. The American College of Emergency Physicians recently withdrew a 2009 white paper endorsing the concept, and California has banned it as a cause of death. Other states may follow suit.

On this week’s episode, we are joined by Utsha G. Khatri, an assistant professor of emergency medicine and population health and policy at the Icahn School of Medicine at Mount Sinai, and emergency physician Brooks Walsh, who was involved with the campaign to get ACEP to withdraw the 2009 white paper. Khatri and Walsh speak about why the “excited delirium” label is both unnecessary and dangerous.

“We recognize that some patients are confused. They’re not thinking clearly they might have risk for becoming violent either toward themselves or towards other staff,” Khatri said. “It is our job not just to keep them and everyone else safe, but also to most importantly find out what is causing them to act in this way.”

You can read Khatri’s First Opinion essay on the end of “excited delirium” here.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： A new crop of companies is reshaping the health data economy

WSS

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Dems pitch expanding Medicare power to negotiate drug prices

Researchers tackle phage therapy hurdles for wider adoption

How doctors’ personal politics affect patients

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Biden warns of ‘dark winter’ during final presidental debate

leisure time

knowledge

hotspot

Drug repurposing or repositioning? The language matters

Opioid cravings were reduced by anti

State Dept. review finds Biden bears some blame for Afghanistan failures

Secretariat’s lessons for human medicine

Anesthesiologist group: stop taking Ozempic before surgery

A new crop of companies is reshaping the health data economy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Former reverend arrested for allegedly killing 8

Dobbs anniversary: the lost opportunity of abortion as health care

Congress may force more Covid

hotspot

Biden warns of ‘dark winter’ during final presidental debate

Truvian presents data for its desktop blood

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

The battle over 'scope creep' and who gets to be called 'doctor'

STAT Report: Patient voices and perspectives

Roche’s Alnylam deal shows drug firms interested in heart drugs

knowledge

focus

explore

focus